UBS Group
AFJK

UBS Group’s Aimei Health Technology Co AFJK Stock Holding History

UBS Group’s Portfolio AFJK Stock Details AFJK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79K Buy
59
+45
+321% +$1.81K ﹤0.01% 9471
2026
Q1 		$343 Sell
14
-1,300
-99% -$57.2K ﹤0.01% 9938
2025
Q4 		$84.1K Sell
1,314
-2,643
-67% -$57.6K ﹤0.01% 6996
2025
Q3 		$44.8K Sell
3,957
-344
-8% -$3.87K ﹤0.01% 7639
2025
Q2 		$47.6K Buy
4,301
+1
+0% +$11 ﹤0.01% 7815
2025
Q1 		$47.3K Hold
4,300
– – ﹤0.01% 7639
2024
Q4 		$46K Buy
+4,300
New +$45.5K ﹤0.01% 7353
2024
Q3 		– Sell
-1,205
Closed -$12.5K – 9453
2024
Q2 		$12.5K Buy
1,205
+1,171
+3,444% +$12.1K ﹤0.01% 7598
2024
Q1 		$347 Buy
+34
New +$346 ﹤0.01% 8616

Other funds holding AFJK

FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group's AFJK Position: Q2 2026 in Review

UBS Group increased its Aimei Health Technology Co (AFJK) stake by 321% in Q2 2026, buying an estimated $1.81K and bringing the position to 59 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #9471.

UBS Group first reported a position in AFJK in Q1 2024 and has held it in 9 quarters since. The position peaked at $84.1K in Q4 2025. 7 funds tracked by Wall St. Rank hold AFJK as of Q2 2026.

  • UBS Group held 59 shares of Aimei Health Technology Co worth $1.79K as of Q2 2026.
  • UBS Group bought 45 Aimei Health Technology Co shares in Q2 2026, an estimated $1.81K.
  • Aimei Health Technology Co made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9471 holding.
  • UBS Group first reported a position in Aimei Health Technology Co in Q1 2024 and has held it in 9 quarters since.
  • UBS Group's Aimei Health Technology Co position peaked at $84.1K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.